Zhengye Biotechnology Holding Limited
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | -45.5% | +178.0% | -14.8% | -67.5% | |
| – | +17.4% | +27.2% | +1.0% | +7.4% | |
| – | – | – | – | – | |
| – | +3.5% | -57.6% | +139.4% | -54.5% | |
| – | +4.0% | -56.9% | – | – | |
| – | +93.9% | +84.1% | -59.4% | +0.0% | |
| – | +336.0% | -28.4% | -111.0% | +341.7% | |
| – | – | -241.1% | +16.6% | – | |
| – | +39.1% | +403.8% | -149.2% | – | |
| – | -284.7% | – | -63.7% | -94.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.